Icu Medical Inc. (ICUI)

Swiss National Bank Lowers Stock Position in ICU Medical, Inc. (NASDAQ:ICUI)

Swiss National Bank decreased its holdings in ICU Medical, Inc. (NASDAQ:ICUI – Free Report) by 10.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,419 shares of the medical instruments supplier’s stock after selling 4,600 shares during the quarter. Swiss National Bank owned about 0.17% of ICU Medical worth $4,031,000 at the end of the most recent quarter. A number of other large investors have also recently bought and sold shares of ICUI. WCM Investment Management LLC boosted its stake in shares of ICU Medical by 37.5% during the fourth quarter. WCM Investment Management LLC now owns 242,808 shares of the medical instruments supplier’s stock worth $24,223,000 after buying an additional 66,221 shares during the period. State of Alaska Department of Revenue grew its stake in shares of ICU Medical by 417.8% in the 4th quarter. State of Alaska Department of Revenue now owns 12,475 shares of the medical instruments supplier’s stock valued at $1,244,000 after purchasing an additional 10,066 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of ICU Medical by 7.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 168,957 shares of the medical instruments supplier’s stock valued at $20,108,000 after purchasing an additional 11,364 shares during the period. Louisiana State Employees Retirement System acquired a new position in shares of ICU Medical in the fourth quarter valued at approximately $1,007,000. Finally, Federated Hermes Inc. raised its stake in shares of ICU Medical by 6.5% during the third quarter. Federated Hermes Inc. now owns 125,967 shares of the medical instruments supplier’s stock worth $14,991,000 after purchasing an additional 7,675 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock. Wall Street Analyst Weigh In Separately, KeyCorp boosted their price objective on shares of ICU Medical from $134.00 to $136.00 and gave the company an “overweight” rating in a research note on Wednesday, February 28th. Check Out Our Latest Report on ICU Medical Insider Activity at ICU Medical In other ICU Medical news, Director Elisha W. Finney sold 300 shares of the company’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $104.95, for a total transaction of $31,485.00. Following the transaction, the director now directly owns 2,129 shares in the company, valued at $223,438.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other ICU Medical news, COO Christian B. Voigtlander sold 13,603 shares of the business’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $107.19, for a total transaction of $1,458,105.57. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Elisha W. Finney sold 300 shares of the firm’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $104.95, for a total value of $31,485.00. Following the completion of the transaction, the director now owns 2,129 shares of the company’s stock, valued at approximately $223,438.55. The disclosure for this sale can be found here. Insiders sold 26,562 shares of company stock worth $2,788,117 over the last 90 days. Company insiders own 6.70% of the company’s stock. ICU Medical Stock Performance NASDAQ ICUI opened at $103.99 on Monday. The stock has a market capitalization of $2.53 billion, a price-to-earnings ratio of -42.44 and a beta of 0.72. The business’s 50 day moving average is $100.63 and its two-hundred day moving average is $97.29. ICU Medical, Inc. has a 12-month low of $78.28 and a 12-month high of $196.57. The company has a current ratio of 2.61, a quick ratio of 1.09 and a debt-to-equity ratio of 0.76. ICU Medical (NASDAQ:ICUI – Get Free Report) last announced its quarterly earnings data on Tuesday, February 27th. The medical instruments supplier reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $0.85 by $0.39. ICU Medical had a positive return on equity of 5.38% and a negative net margin of 2.63%. The firm had revenue of $587.86 million for the quarter, compared to analyst estimates of $564.77 million. Research analysts expect that ICU Medical, Inc. will post 3.53 EPS for the current year. ICU Medical Company Profile (Free Report) ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.